Teva Pharmaceutical Industries (TEVA) Other Operating Expenses: 2017-2025
Historic Other Operating Expenses for Teva Pharmaceutical Industries (TEVA) over the last 9 years, with Sep 2025 value amounting to -$7.0 million.
- Teva Pharmaceutical Industries' Other Operating Expenses fell 133.33% to -$7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.0 million, marking a year-over-year decrease of 185.71%. This contributed to the annual value of $14.0 million for FY2024, which is 71.43% down from last year.
- As of Q3 2025, Teva Pharmaceutical Industries' Other Operating Expenses stood at -$7.0 million, which was down 75.00% from -$4.0 million recorded in Q2 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Other Operating Expenses ranged from a high of $52.0 million in Q1 2022 and a low of -$8.0 million during Q4 2024.
- In the last 3 years, Teva Pharmaceutical Industries' Other Operating Expenses had a median value of $2.0 million in 2024 and averaged $4.4 million.
- Its Other Operating Expenses has fluctuated over the past 5 years, first surged by 940.00% in 2022, then crashed by 400.00% in 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Other Operating Expenses (Quarterly) stood at $25.0 million in 2021, then fell by 24.00% to $19.0 million in 2022, then plummeted by 68.42% to $6.0 million in 2023, then tumbled by 233.33% to -$8.0 million in 2024, then plummeted by 133.33% to -$7.0 million in 2025.
- Its Other Operating Expenses was -$7.0 million in Q3 2025, compared to -$4.0 million in Q2 2025 and -$5.0 million in Q1 2025.